Suita, Japan

Fujie Tanaka

This inventor holds 1 USPTO granted patent. Top assignee: Protein Engineering Research Institute. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fujie Tanaka. Retrieved from https://idiyas.com/inventor/fujie-tanaka-2ln7rev1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fujie Tanaka: Innovator in Catalytic Antibodies

Introduction

Fujie Tanaka is a notable inventor based in Suita, Japan. He has made significant contributions to the field of protein engineering, particularly in the development of catalytic antibodies.

Latest Patents

Fujie Tanaka holds a patent for "Catalytic antibodies enantioselectively hydrolysing amino acid ester." This innovative work showcases his expertise in creating antibodies that can selectively catalyze reactions, which is crucial for various biochemical applications. He has 1 patent to his name.

Career Highlights

Tanaka is affiliated with the Protein Engineering Research Institute, where he continues to push the boundaries of research in protein engineering. His work has implications for drug development and therapeutic applications.

Collaborations

He has collaborated with notable colleagues, including Ikuo Fujii and Keiko Kinoshita, who contribute to the dynamic research environment at the institute.

Conclusion

Fujie Tanaka's innovative work in catalytic antibodies exemplifies the advancements being made in protein engineering. His contributions are paving the way for future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…